Abstract:Osteosarcoma is an aggressive malignant bone tumour, affecting paediatric and young adult patients. The study combine scaffold, calcium phosphate cements (SrCPC) with drug anticancer methotrexate and doxorubicin. Doped‐SrCPC induce the apoptosis process on SAOS‐2 and U2‐OS tumour cells. Material demonstrates a good cytocompatibility and stimulates bone regrowth through stem cell differentiation. Osteosarcoma (OS) cancer treatments include systemic chemotherapy and surgical resection. In the last years, novel treatment approaches have been proposed, which employ a drug‐delivery system to prevent offside effects and improves treatment efficacy. Locally delivering anticancer compounds improves on high local concentrations with more efficient tumour‐killing effect, reduced drugs resistance and confined systemic effects. Here, the synthesis of injectable strontium‐doped calcium phosphate (SrCPC) scaffold was proposed as drug delivery system to combine bone tissue regeneration and anticancer treatment by controlled release of methotrexate (MTX) and doxorubicin (DOX), coded as SrCPC‐MTX and SrCPC‐DOX, respectively. The drug‐loaded cements were tested in an in vitro model of human OS cell line SAOS‐2, engineered OS cell line (SAOS‐2‐eGFP) and U2‐OS. The ability of doped scaffolds to induce OS cell death and apoptosis was assessed analysing cell proliferation and Caspase‐3/7 activities, respectively. To determine if OS cells grown on doped‐scaffolds change their migratory ability and invasiveness, a wound‐healing assay was performed. In addition, the osteogenic potential of SrCPC material was evaluated using human adipose derived‐mesenchymal stem cells. Osteogenic markers such as (i) the mineral matrix deposition was analysed by alizarin red staining; (ii) the osteocalcin (OCN) protein expression was investigated by enzyme‐linked immunosorbent assay test, and (iii) the osteogenic process was studied by real‐time polymerase chain reaction array. The delivery system induced cell‐killing cytotoxic effects and apoptosis in OS cell lines up to Day 7. SrCPC demonstrates a good cytocompatibility and it induced upregulation of osteogenic genes involved in the skeletal development pathway, together with OCN protein expression and mineral matrix deposition. The proposed approach, based on the local, sustained release of anticancer drugs from nanostructured biomimetic drug‐loaded cements is promising for future therapies aiming to combine bone regeneration and anticancer local therapy.

Design and synthesis of Berberine loaded Nano-hydroxyapatite/Gelatin Scaffold for bone cancer treatment

Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM-PLGA microspheres for bone cancer treatment

The Application of 3D-Printing and Nanotechnology for the Targeted Treatment of Osteosarcoma

A multiple drug loaded, functionalized pH-sensitive nanocarrier as therapeutic and epigenetic modulator for osteosarcoma

Osteosarcoma cell death induced by innovative scaffolds doped with chemotherapeutics

Borocarbonitrides Nanosheets Engineered 3D-Printed Scaffolds for Integrated Strategy of Osteosarcoma Therapy and Bone Regeneration

Bioinspired Tumor‐Targeting and Biomarker‐Activatable Cell‐Material Interfacing System Enhances Osteosarcoma Treatment via Biomineralization

Fabrication and characterization of 3D-printed composite scaffolds of coral-derived hydroxyapatite nanoparticles/polycaprolactone/gelatin carrying doxorubicin for bone tissue engineering

Fabrication of Micro-Nano Bioactive Glass Scaffold Incorporated with Siglec-15 for Bone Repair and Postoperative Treatment of Osteosarcoma

The Potential Selective Cytotoxicity of Poly (L- Lactic Acid)-Based Scaffolds Functionalized with Nanohydroxyapatite and Europium (III) Ions toward Osteosarcoma Cells

Design of Alveolate Se-Inserted Tio2 and Its Effect on Osteosarcoma Cells and Osteoblasts

MXene-Based Hydrogels Endow Polyetheretherketone with Effective Osteogenicity and Combined Treatment of Osteosarcoma and Bacterial Infection

Zoledronic Acid-Loaded Hybrid Hyaluronic Acid/Polyethylene Glycol/Nano-Hydroxyapatite Nanoparticle: Novel Fabrication and Safety Verification

Development of pH-Sensitive Alendronate-Decorated Silk Fibroin/ Alginate Nanoparticles for Active Targeting of Doxorubicin to Bone Cancers

Natural Drug-Loaded Bimetal-Substituted Hydroxyapatite-Polymeric Composite for Osteosarcoma-Affected Bone Repair

Synthesis and biophysical characterization of porous bi-phase calcium phosphate/gelatin-PVA scaffold: Enhanced antibacterial, osteoconductivity and anticancer activity via silver nanoparticles and methotrexate incorporation

Biomimetic Polydopamine-Modified Silk Fibroin/Curcumin Nanofibrous Scaffolds for Chemo-photothermal Therapy of Bone Tumor

Exploring the frontiers: The potential and challenges of bioactive scaffolds in osteosarcoma treatment and bone regeneration

3D-printed tri-element-doped hydroxyapatite/ polycaprolactone composite scaffolds with antibacterial potential for osteosarcoma therapy and bone regeneration

Supercritical CO2-assisted fabrication of CM-PDA/SF/nHA nanofibrous scaffolds for bone regeneration and chemo-photothermal therapy against osteosarcoma